JASEK, Karin, Marian GRENDAR, Andrea STANCLOVA, Bibiana MALICHEROVA, Ivana KASUBOVA, Tatiana BURJANIVOVA, Peter SZEPE, Rachele CICCOCIOPPO, Luis RODRIGO, Robert PROSECKÝ, Peter KRUŽLIAK, Lukas PLANK and Zora LASABOVA. Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients. Journal of cancer research and clinical oncology. Germany: Springer-Verlag, 2021, vol. 147, No 4, p. 1203-1215. ISSN 0171-5216. Available from: https://dx.doi.org/10.1007/s00432-020-03410-8.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients
Authors JASEK, Karin, Marian GRENDAR (703 Slovakia), Andrea STANCLOVA (703 Slovakia), Bibiana MALICHEROVA (703 Slovakia), Ivana KASUBOVA (703 Slovakia), Tatiana BURJANIVOVA (703 Slovakia), Peter SZEPE (703 Slovakia), Rachele CICCOCIOPPO (380 Italy), Luis RODRIGO (724 Spain), Robert PROSECKÝ (203 Czech Republic, belonging to the institution), Peter KRUŽLIAK (703 Slovakia), Lukas PLANK (703 Slovakia) and Zora LASABOVA (703 Slovakia).
Edition Journal of cancer research and clinical oncology, Germany, Springer-Verlag, 2021, 0171-5216.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.322
RIV identification code RIV/00216224:14110/21:00120776
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s00432-020-03410-8
UT WoS 000577037900001
Keywords in English Gastrointestinal stromal tumors; Single nucleotide polymorphism; c; 1621 A > C; M541L; c-KIT
Tags 14110116, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 8/4/2021 11:00.
Abstract
Background Single nucleotide polymorphisms can create a genetic microenvironment in some tumors that affects the course of treatment, resistance, etc. Whether single nucleotide polymorphisms have an impact on gastrointestinal stromal tumor (GIST) development and disease progression is not yet accurately verified.KITSNP(M541L)in exon 10 correlates with a worse prognosis of many cancers. The impact ofKITSNP(M541L)in GISTs is relatively unknown and, therefore, its analyses could have potential in patient therapy and could provide more detailed information on tumor character, clinical presentation, or tumor behavior in treatment. Aim The aim of the study was the analysis of the biological and clinical significance of theKITSNP(M541L)polymorphism in exon 10. Materials and methods Paraffin sample tissues were obtained from the National GIST Register in Martin. Retrospective samples from 177 GIST patients were divided into several groups. Detection of SNP(M541L)was performed by Sanger sequencing. Statisitical analyses were performed to determine the prevalence ofKITSNP(M541L)in the Slovak GIST cohort, to search for correlation betweenc-KITstatus and clinicopathological, molecular and biological data. Results Overall, 29 samples out of 177 showedKITSNP(M541L)polymorphism. Conclusion Our results do not support the association betweenKITSNP(M541L)and increased risk of relapse in localized primary GISTs. Additionally, we found a positive correlation betweenKITSNP(M541L)occurrence and earlier onset of relapse inPDGFRaand WT subgroup of GISTs.
PrintDisplayed: 21/5/2024 21:01